Ospolot, containing the active ingredient sulthiame, is an anticonvulsant medication primarily used in the treatment of various forms of epilepsy, especially in children. It is known to be effective in managing partial and generalized seizures. Recent research is also exploring its potential in treating obstructive sleep apnoea (OSA), although this use is still under investigation.